Indian Journal of Respiratory Care

IJRC Email      Register      Login

VOLUME 10 , ISSUE S1 ( April, 2021 ) > List of Articles


Respiratory System-The Port of Entry of SARS-COV-2 with Special Reference to Aerosol Management

Muralidhar Kanchi, Moumita Chakraborthy, Amal T J Joseph, P Sibiya Poonely Chacko

Keywords : Aerosol-generating procedure, barrier devices in COVID-19, pathophysiology of COVID-19, personal protective equipment, transmission of severe acute respiratory syndrome coronavirus-2

Citation Information :

DOI: 10.4103/ijrc.ijrc_131_20

License: CC BY-NC-SA 4.0

Published Online: 06-12-2022

Copyright Statement:  Copyright © 2021; Indian Journal of Respiratory Care.


The outbreak of novel coronavirus disease (COVID-19) caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a global pandemic of unprecedented proportions. Management of patients infected with COVID-19 has led to a great risk of hospital-based transmission of infection to health-care professionals (HCPs). The HCPs at various levels in a multispecialty health-care setup are at risk of contracting the virus. Those who are involved with performing or assisting in aerosol-generating procedures (AGPs) have a potentially higher risk of developing the infection. The AGPs involve a wide range of procedures such as pulmonary function testing, high-flow oxygen administration, endotracheal intubation, nebulization, application of ventilators, weaning and extubation, bronchoscopy, tracheostomy, and cardiopulmonary resuscitation. Hence, understanding the overall nature of the disease is of vital importance to develop preventive strategies to reduce transmission of the virus through aerosols. This review article intends to elucidate the port of entry associated with SARS-CoV-2 infection and its spread through the AGPs. We also intend to focus on methods to prevent aerosol-related transmission of infection to HCPs by illustrating clinically practiced evidence-based protocol followed in our multispecialty health-care setup.

  1. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. Author correction: A new coronavirus associated with human respiratory disease in China. Nature 2020;580:E7.
  2. Reusken CB, Buiting A, Bleeker-Rovers C, Diederen B, Hooiveld M, Friesema I, et al. Rapid assessment of regional SARS-CoV-2 community transmission through a convenience sample of healthcare workers, the Netherlands, March 2020. Euro Surveill 2020;25:2000334.
  3. Behzad S, Aghaghazvini L, Radmard AR, Gholamrezanezhad A. Extrapulmonary manifestations of COVID-19: Radiologic and clinical overview. Clin Imaging 2020;66:35-41.
  4. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Napoli RD. Features, Evaluation and Treatment Coronavirus (COVID-19). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020 January. Available from: [Last accessed on 2020 Nov 11; Last updated on 2020 Jul 04].
  5. Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32.
  6. Arabi YM, Arifi AA, Balkhy HH, Najm H, Aldawood AS, Ghabashi A, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med 2014;160:389-97.
  7. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA 2020;324:782-93.
  8. Bosch BJ, van der Zee R, de Haan CA, Rottier PJ. The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex. J Virol 2003;77:8801-11.
  9. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003;426:450-4.
  10. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579:270-3.
  11. Cao W, Li T. COVID-19: towards understanding of pathogenesis. Cell Res 2020;30:367-9.
  12. Bombardini T, Picano E. Angiotensin-converting enzyme 2 as the molecular bridge between epidemiologic and clinical features of COVID-19. Can J Cardiol 2020;36:784.e1-0.
  13. Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020;367:1260-3.
  14. Li F, Li W, Farzan M, Harrison SC. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 2005;309:1864-8.
  15. Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care 2020;24:422.
  16. Perrotta F, Matera MG, Cazzola M, Bianco A. Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter? Respir Med 2020;168:105996.
  17. Harding H, Broom A, Broom J. Aerosol-generating procedures and infective risk to healthcare workers from SARS-CoV-2: The limits of the evidence. J Hosp Infect 2020;105:717-25.
  18. Howard BE. High-risk aerosol-generating procedures in COVID-19: Respiratory protective equipment considerations. Otolaryngol Head Neck Surg 2020;163:98-103.
  19. Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: A systematic review. PLoS One 2012;7:e35797.
  20. Wong KC, Leung KS. Transmission and prevention of occupational infections in orthopaedic surgeons. J Bone Joint Surg Am 2004;86:1065-76.
  21. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323:1061-9.
  22. Dhand R, Li J. Coughs and sneezes: Their role in transmission of respiratory viral infections, including SARS-CoV-2. Am J Respir Crit Care Med 2020;202:651-9.
  23. Sommerstein R, Fux CA, Vuichard-Gysin D, et al. Risk of SARS-CoV-2 transmission by aerosols, the rational use of masks, and protection of healthcare workers from COVID-19. Antimicrob Resist Infect Control 2020;100:9.
  24. Wei J, Li Y. Airborne spread of infectious agents in the indoor environment. Am J Infect Control 2016;44:S102-8.
  25. Bourouiba L. Turbulent gas clouds and respiratory pathogen emissions: Potential implications for reducing transmission of COVID-19. JAMA 2020;323:1837-8.
  26. Tang JW, Liebner TJ, Craven BA, Settles GS. A schlieren optical study of the human cough with and without wearing masks for aerosol infection control. J R Soc Interface 2009;6 Suppl 6:S727-36.
  27. Anfinrud P, Stadnytskyi V, Bax CE, Bax A. Visualizing speech-generated oral fluid droplets with laser light scattering. N Engl J Med 2020;382:2061-3.
  28. Weaver GH. Droplet infection and its prevention by the face masks J Infect Dis 1919;24:218-30.
  29. Setti L, Passarini F, De Gennaro G, Barbieri P, Perrone MG, Borelli M, et al. Airborne transmission route of COVID-19: Why 2 meters/6 feet of inter-personal distance could not be enough. Int J Environ Res Public Health 2020;17:2932.
  30. Kumar GP, Kulkarni AP, Govil D, Dixit SB, Chaudhry D, Samavedam S, et al. Airway management and related procedures in critically Ill COVID-19 patients: Position statement of the Indian society of critical care medicine. Indian J Crit Care Med 2020;24:630-42.
  31. Panuganti BA, Pang J, Califano J, Chan JY. Procedural precautions and personal protective equipment during head and neck instrumentation in the COVID-19 era. Head Neck 2020;42:1645-51.
  32. Infection Prevention and Control of Epidemic- and Pandemic-Prone Acute Respiratory Infections in Health Care. Geneva: World Health Organization; 2014.
  33. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 2020;382:1564-7.
  34. Roy A, Singh A, Khanna P. Oxygen delivery devices in COVID-19 patients: Review and recommendation. Bali J Anaesthesiol 2020;4 Suppl S1:3-7.
  35. Hui DS, Chan MT, Chow B. Aerosol dispersion during various respiratory therapies: A risk assessment model of nosocomial infection to health care workers. Hong Kong Med J 2014;20 Suppl 4:9-13.
  36. Katiyar SK, Katiyar S. Nebulization in the pandemic of coronavirus disease 2019. Indian J Allergy Asthma Immunol 2020;34:8-14.
  37. Xia JG, Zhao JP, Cheng ZS, Hu Y, Duan J, Zhan QY. Non-invasive respiratory support for patients with novel coronavirus pneumonia: Clinical efficacy and reduction in risk of infection transmission. Chin Med J (Engl) 2020;133:1109-11.
  38. Esquinas AM, Egbert PS, Scala R, Gay P, Soroksky A, Girault C. Noninvasive mechanical ventilation in high-risk pulmonary infections: A clinical review. Eur Resp Rev 2014;23:427-38.
  39. Raboud J, Shigayeva A, McGeer A, Bontovics E, Chapman M, Gravel D, et al. Risk factors for SARS transmission from patients requiring intubation: A multicentre investigation in Toronto, Canada. PLoS One 2010;5:e10717.
  40. Simonds AK, Hanak A, Chatwin M, Morrell M, Hall A, Parker KH, et al. Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: Implications for management of pandemic influenza and other airborne infections. Health Technol Assess 2010;14:131-72.
  41. Cook TM. Personal protective equipment during the coronavirus disease (COVID) 2019 pandemic - A narrative review. Anaesthesia 2020;75:920-7.
  42. Chung FF, Lin HL, Liu HE, Lien AS, Hsiao HF, Chou LT, et al. Aerosol distribution during open suctioning and long-term surveillance of air quality in a respiratory care center within a medical center. Respir Care 2015;60:30-7.
  43. De Seta D, Carta F, Puxeddu R. Management of tracheostomy during COVID-19 outbreak: Heat and moisture exchanger filter and closed suctioning system. Oral Oncol 2020;106:104777.
  44. Vargas M, Servillo G. Closed-suction System for intubated COVID-19 patients with the use of an ultrasound probe cover. Anesthesiology 2020;133:687-9.
  45. Orser Beverley A. Recommendations for endotracheal intubation of COVID-19 patients. Anesth Analg 2020;130:1109-10.
  46. Odor PM, Neun M, Bampoe S, Clark S, Heaton D, Hoogenboom EM, et al. Anaesthesia and COVID-19: Infection control. Br J Anaesth 2020;125:16-24.
  47. Chan MTV, Chow BK, Lo T, Ko FW, Ng SS, Gin T, et al. Exhaled air dispersion during bag-mask ventilation and sputum suctioning - Implications for infection control. Sci Rep 2018;8:198.
  48. Vijayaraghavan S, Puthenveettil N. Aerosol box for protection during airway manipulation in COVID-19 patients. Indian J Anaesth 2020;64:S148-S149.
  49. Zeidan A, Bamadhaj M, Al-Faraidy M, Ali M. Videolaryngoscopy intubation in patients with COVID-19: How to minimize risk of aerosolization? Anesthesiology 2020;133:481-3.
  50. O'Neil CA, Li J, Leavey A, Wang Y, Hink M, Wallace M, et al. Centers for disease control and prevention epicenters program. Characterization of aerosols generated during patient care activities. Clin Infect Dis 2017;65:1335-41.
  51. Doggett N, Chow CW, Mubareka S. Characterization of experimental and clinical bioaerosol generation during potential aerosol-generating procedures. Chest 2020;158:2467-73.
  52. Lavoie J, Marchand G, Cloutier Y, Hallé S, Nadeau S, Duchaine C, et al. Evaluation of bioaerosol exposures during hospital bronchoscopy examinations. Environ Sci Process Impacts 2015;17:288-99.
  53. Liu W, Tang F, Fang LQ, Vlas SJ, Ma HJ, Zhou JP. Riskfactors for SARS infection among hospital healthcare workers in Beijing: A case control study. Trop Med Int Health 2009;14:52-9.
  54. Ott M, Milazzo A, Liebau S, Jaki C, Schilling T, Krohn A, et al. Exploration of strategies to reduce aerosol-spread during chest compressions: A simulation and cadaver model. Resuscitation 2020;152:192-8.
  55. World Health Organization. Coronavirus Disease 2019 (COVID-19) Situation Report - 82. Geneva: WHO; 2020. Available from: [Last accessed on 2021 Feb 07].
  56. Centers for Disease Control and Prevention. Using Personal Protective Equipment (PPE). Available from: [Last accessed on 2021 Feb 07; Last updated on 2020 Aug 19].
  57. Singh B, Singla SL, Gulia P, Kumar A, Bhanwala R. Aerosol containment device for use on suspected COVID-19 patients. Indian J Anaesth 2020;64:S154-S156.
  58. Gonzalez R, Schaefer John J, Krohner Robert G. Simple Method for Reducing Risk for Aerosolized COVID-19 Transmission During Intubation Aand Extubation: The Surgical Smoke Evacuator. Available from: cing-Risk-for-Aerosolized-COVID-19-Transmission-During-Intub ation-and-Extubation-The-Surgical-Smoke-Evacuator/59168. [Last accessed on 2020 Nov 11].
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.